Polaris Management Co. Vii, L.L.C. Insider Trades

Insider Trading History

Track insider trading activity for Polaris Management Co. Vii, L.L.C.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Calamp
Calamp CAMP
10% owner
Holding Value $12.3M 2,825,500 shares
Last Trade
Sep 11, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.63M 1,307,189 shares
$2.78
$4.37
SQZ Biotechnologies
SQZ Biotechnologies SQZ
10% owner
Holding Value $0 0 shares
Last Trade
Nov 03, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$35.7M 2,199,101 shares
$16.25
$0.44
SQZ Biotechnologies
SQZ Biotechnologies SQZ
10% owner
Holding Value $0 0 shares
Last Trade
Oct 29, 2020 Sale
No data
No data
$0.44
SQZ Biotechnologies
SQZ Biotechnologies SQZ
10% owner
Holding Value $0 0 shares
Last Trade
Oct 29, 2020 Sale
No data
No data
$0.44
SQZ Biotechnologies
SQZ Biotechnologies SQZ
10% owner
Holding Value $0 0 shares
Last Trade
Oct 29, 2020 Sale
No data
No data
$0.44
SQZ Biotechnologies
SQZ Biotechnologies SQZ
10% owner
Holding Value $0 0 shares
Last Trade
Oct 29, 2020 Sale
No data
No data
$0.44
Metacrine
Metacrine MTCR
10% owner
Holding Value $1.58M 2,715,316 shares
Last Trade
Sep 18, 2020 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$26.9M 2,664,258 shares
$10.10
$0.58
Metacrine
Metacrine MTCR
10% owner
Holding Value $0 0 shares
Last Trade
Sep 18, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.66M 163,904 shares
$10.10
$0.58
Metacrine
Metacrine MTCR
10% owner
Holding Value $125k 214,962 shares
Last Trade
Sep 18, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.32M 230,000 shares
$10.10
$0.58
Metacrine
Metacrine MTCR
10% owner
Holding Value $0 0 shares
Last Trade
Sep 15, 2020 Sale
No data
No data
$0.58
Metacrine
Metacrine MTCR
10% owner
Holding Value $0 0 shares
Last Trade
Sep 15, 2020 Sale
No data
No data
$0.58
Metacrine
Metacrine MTCR
10% owner
Holding Value $0 0 shares
Last Trade
Sep 15, 2020 Sale
No data
No data
$0.58
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
10% owner
Holding Value $0 0 shares
Last Trade
Jul 06, 2016 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.5M 83,129 shares
$18.00
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
10% owner
Holding Value $615 1,538,333 shares
Last Trade
Jul 06, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.73M 373,847 shares
$18.00
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
10% owner
Holding Value $466 1,164,486 shares
Last Trade
Jul 06, 2016 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$21M 1,164,486 shares
$18.00
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
10% owner
Holding Value $19.3 48,320 shares
Last Trade
Jul 06, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$471k 26,153 shares
$18.00
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
10% owner
Holding Value $8.87 22,167 shares
Last Trade
Jul 06, 2016 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$399k 22,167 shares
$18.00
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
10% owner
Holding Value $0 0 shares
Last Trade
Jun 29, 2016 Sale
No data
No data
$0.00
Syros Pharmaceuticals
Syros Pharmaceuticals SYRS
Director
Holding Value $0 0 shares
Last Trade
Jun 29, 2016 Sale
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up